FDA Recall
Terminated
PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.
Recall: Z-0368-2016
·
Initiated October 26, 2015
Recall
- Recall Number
- Z-0368-2016
- Event Number
- 72591
- Firm
- Merz North America, Inc.
- FEI Number
- 1012187
- Product Code
- KHJ
- Status
- Terminated
- Root Cause
- Other
- Initiated
- October 26, 2015
- Posted
- December 3, 2015
- Terminated
- May 8, 2017
- Address
- 6501 Six Forks Rd, Raleigh, NC, 27615-6515
Description
PROLARYN PLUS Injectable Implant 1.0 cc Plus Calcium Hydroxlyapatite (CaHA) Injectable Implant, Model No. 8044M0K5. An injectable implant used to treat vocal fold insufficiency.
Reason
The expiration date encoded in the UDI barcode on the label on the product carton and the peelable patient identification label is incorrect.
Action
Letters were issued 11/4/2015 to consignees. The letter informs the consignees that they can continue to safely use the affected products by referring to the USE BEFORE date. They letter does not require for any product to be returned. Also, there is no sub-recall required as the product was not distributed to distributors or wholesalers.
Distribution
Distributed US (nationwide) including the Virgin Islands and South Africa.
Quantity
9,439 units